Salivary Lysozymes, Anti-inflammatory Cardiac Medications, and Cardiovascular Mortality.
Researchers followed 471 people over 18.8 years and found that higher baseline salivary lysozyme levels were associated with increased cardiovascular mortality risk, independent of systemic inflammation markers or anti-inflammatory cardiac medications.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Managing the Pregnant Dental Patient
Confident, evidence-based dental care from the first trimester to the postpartum period
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall